文明病药物市场：依治疗类型、剂型及分布划分－2025-2030年全球预测

文明病药物市场规模2023年为209.4亿美元，预估2024年将达221.4亿美元，复合年增长率为5.82%，2030年将达311.2亿美元。

文明病是指旨在透过治疗不危及生命的主观症状（例如勃起功能障碍、肥胖、忧郁症和戒烟）来改善生活品质的药物。这些药物满足了重视个人福祉和进步的社会的需求，并为医学和文化转型铺平了道路。全球对日常生活中药物增强的接受度不断提高，加上生活方式带来的压力、不良饮食习惯和久坐习惯，推动了对治疗与文明病的药物的需求。应用主要包括心血管、性功能障碍、心理健康和皮肤科，最终用途着重于便利性，例如医院、诊所和个人家庭使用。市场成长受到健康意识提高、可支配收入增加以及给药方法技术进步的显着影响。最近潜在的商机源于对个人化医疗和远端医疗的快速增长的兴趣。然而，监管监督、道德考虑以及与文明病药物被视为非必需品或奢侈品的风险等限制因素可能会限制市场渗透。此外，围绕着使用这些药物的社会和文化耻辱以及潜在的副作用对市场成长构成了进一步的挑战。创新领域包括开拓环保和生物基药物配方、人工智慧驱动的标靶药物传输以及整合行动医疗应用程式以进行全面的生活方式管理。在消费者趋势和技术采用的推动下，市场格局是动态的，这表明前景广阔但竞争激烈。企业必须投资消费者教育计划并与数位健康平台建立策略伙伴关係关係，以有效地进入这个不断扩大的市场。

市场动态：快速发展的文明病治疗市场的关键市场洞察

由于供需的动态互动，文明病治疗药物市场正在经历转型。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

• 市场驱动因素
  • 不健康的饮食习惯和久坐的生活方式根深蒂固
  • 个人健身和健康意识不断增强
  • 性功能障碍和荷尔蒙失衡的增加
• 市场限制因素
  • 产品高成本
• 市场机会
  • 增加药物开发的研究和开发
  • 美容和护肤治疗支出增加
• 市场挑战
  • 与文明病药物相关的副作用

波特五力：驾驭文明病药物市场的策略工具

波特的五力架构是了解文明病药物市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解文明病治疗药品市场的外部影响

外部宏观环境因素在塑造文明病药物市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解文明病治疗药物市场的竞争状况

对文明病治疗药物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV文明病药物市场供应商的定位矩阵绩效评估

FPNV定位矩阵是评估文明病医学市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘文明病治疗药物市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，与文明病药物市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 采取不健康的饮食习惯和久坐的生活方式
    • 个人健身和健康意识不断增强
    • 性功能障碍和荷尔蒙失衡增加
  • 抑制因素
    • 产品成本高
  • 机会
    • 加强药物研发的研究与开发
    • 美容和护肤治疗支出增加
  • 任务
    • 与文明病药物相关的不良反应
• 市场区隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章依治疗类型文明病药物市场

• 皮肤科
• 失眠
• 肥胖
• 性功能障碍
• 吸烟
• 妇女健康

第七章文明病治疗药物市场：依形式

• 奶油
• 凝胶
• 口服糖浆
• 药片

第八章文明病治疗药品市场经销商

• 医院药房
• 线上管道
• 零售药房

第九章 北美和南美文明病治疗药物市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第十章 亚太地区文明病药物市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十一章 欧洲、中东和非洲文明病治疗药物市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十二章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
• 战略分析和建议

公司名单

• Alembic Pharmaceuticals Limited
• Amgen, Inc.
• AstraZeneca Plc
• Biocon Limited
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• Eli Lilly and Company
• GlaxoSmithKline Plc
• Johnson & Johnson Services, Inc.
• Lupin Limited
• Merck KGaA
• Novo Nordisk A/S
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• The Procter & Gamble Company
• Viatris Inc.

The Lifestyle Drugs Market was valued at USD 20.94 billion in 2023, expected to reach USD 22.14 billion in 2024, and is projected to grow at a CAGR of 5.82%, to USD 31.12 billion by 2030.

Lifestyle drugs refer to pharmaceuticals designed to improve the quality of life by treating non-life-threatening and often subjective conditions such as erectile dysfunction, obesity, depression, and smoking cessation. These drugs cater to the demands driven by the societal emphasis on personal well-being and enhancement, paving the way for both medical and cultural shifts. The necessity of lifestyle drugs is fueled by an increasing global acceptance of pharmaceutical enhancements in daily life, combined with lifestyles that contribute to stress, poor diets, and sedentary habits. Applications primarily span across cardiovascular health, sexual dysfunction, mental health, and dermatology, with the end-use scope including hospitals, clinics, and personal use at home, emphasizing convenience. Market growth is significantly influenced by rising health awareness, increasing disposable incomes, and technological advancements in drug delivery methods. Recent potential opportunities emerge from the rapidly growing interest in personalized medicine and telehealth, which can facilitate custom lifestyle management plans, expanding reach within previously untapped demographics. However, limitations include regulatory scrutiny, ethical considerations, and the risk of lifestyle drugs being perceived as non-essential or luxury items, which may limit market penetration. Furthermore, societal and cultural stigma surrounding the use of these drugs, alongside potential side effects, pose additional challenges to market growth. Innovative areas ripe for exploration include the development of eco-friendly and bio-based drug formulas, leveraging AI for targeted drug delivery, and integrating mobile health apps for comprehensive lifestyle management. The nature of the lifestyle drugs market is dynamic, driven by consumer trends and technological adoption, suggesting a promising yet competitive landscape. It's crucial for businesses to invest in consumer education initiatives and forge strategic partnerships with digital health platforms to effectively tap into this expanding market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Lifestyle Drugs Market

The Lifestyle Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Adoption of unhealthy eating habits and sedentary lifestyle
  • Increasing awareness regarding personal fitness and health consciousness
  • Rise in sexual disorders and hormonal imbalance
• Market Restraints
  • High cost of products
• Market Opportunities
  • Increasing R&D for drug developments
  • Rising expenditure on beauty and skin care therapeutics
• Market Challenges
  • Adverse effects associated with the lifestyle drugs

Porter's Five Forces: A Strategic Tool for Navigating the Lifestyle Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Lifestyle Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Lifestyle Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Lifestyle Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Lifestyle Drugs Market

A detailed market share analysis in the Lifestyle Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Lifestyle Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Lifestyle Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Lifestyle Drugs Market

A strategic analysis of the Lifestyle Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lifestyle Drugs Market, highlighting leading vendors and their innovative profiles. These include Alembic Pharmaceuticals Limited, Amgen, Inc., AstraZeneca Plc, Biocon Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson Services, Inc., Lupin Limited, Merck KGaA, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceutical Industries Ltd., The Procter & Gamble Company, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Lifestyle Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Therapeutic Type, market is studied across Dermatology, Insomnia, Obesity, Sexual Dysfunction, Smoking, and Women's Health.
• Based on Form, market is studied across Creams, Gels, Oral Syrups, and Tablets.
• Based on Distribution, market is studied across Hospital Pharmacies, Online Channels, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Adoption of unhealthy eating habits and sedentary lifestyle
    • 5.1.1.2. Increasing awareness regarding personal fitness and health consciousness
    • 5.1.1.3. Rise in sexual disorders and hormonal imbalance
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of products
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing R&D for drug developments
    • 5.1.3.2. Rising expenditure on beauty and skin care therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects associated with the lifestyle drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Lifestyle Drugs Market, by Therapeutic Type

• 6.1. Introduction
• 6.2. Dermatology
• 6.3. Insomnia
• 6.4. Obesity
• 6.5. Sexual Dysfunction
• 6.6. Smoking
• 6.7. Women's Health

7. Lifestyle Drugs Market, by Form

• 7.1. Introduction
• 7.2. Creams
• 7.3. Gels
• 7.4. Oral Syrups
• 7.5. Tablets

8. Lifestyle Drugs Market, by Distribution

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Channels
• 8.4. Retail Pharmacies

9. Americas Lifestyle Drugs Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Lifestyle Drugs Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Lifestyle Drugs Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alembic Pharmaceuticals Limited
• 2. Amgen, Inc.
• 3. AstraZeneca Plc
• 4. Biocon Limited
• 5. Cipla Limited
• 6. Dr. Reddy's Laboratories Ltd.
• 7. Eli Lilly and Company
• 8. GlaxoSmithKline Plc
• 9. Johnson & Johnson Services, Inc.
• 10. Lupin Limited
• 11. Merck KGaA
• 12. Novo Nordisk A/S
• 13. Pfizer Inc.
• 14. Teva Pharmaceutical Industries Ltd.
• 15. The Procter & Gamble Company
• 16. Viatris Inc.

LIST OF FIGURES

• FIGURE 1. LIFESTYLE DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. LIFESTYLE DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL LIFESTYLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. LIFESTYLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. LIFESTYLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. LIFESTYLE DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL LIFESTYLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. LIFESTYLE DRUGS MARKET DYNAMICS
• TABLE 7. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SEXUAL DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SMOKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY WOMEN'S HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ORAL SYRUPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 35. CANADA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CHINA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 52. CHINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 55. INDIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ITALY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 107. ITALY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 118. POLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 119. POLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 121. QATAR LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 122. QATAR LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 150. LIFESTYLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. LIFESTYLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023